| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | n/a |
| ROCE | 470.8% |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | n/a | n/a |
| Pr/Book | n/a |
| Latest | F'cast | |
|---|---|---|
| Revenue | n/a | n/a |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Apr-22 | n/a | (6.27) | (5.60)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-23 | 5.27 | (14.30) | (15.00)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-24 | n/a | (9.12) | (6.80)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-25 | 4.71 | (15.30) | (12.60)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Apr-26 | n/a | (20.23) | (17.30)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
No recent information was found.
| /C O R R E C T I O N -- KushoAI/ | 02-Apr-2026 | ShareCast |
| FDA clears Scancell's application for phase thre... | 26-Jan-2026 | ShareCast |
| Scancell reports further data from DNA cancer im... | 09-Dec-2025 | ShareCast |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 86.40p |
| Change Today | -1.60p |
| % Change | -1.82 % |
| 52 Week High | 265.00p |
| 52 Week Low | 86.00p |
| Volume | 58,559 |
| Shares Issued | 121.22m |
| Market Cap | £104.74m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:08 | 20,000 @ 87.00p |
| 16:35 | 10,000 @ 86.40p |
| 16:35 | 9,000 @ 86.40p |
| 16:35 | 1,000 @ 86.40p |
| 16:34 | 2,500 @ 86.00p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research